Thermo Fisher Scientific reported a 9% increase in revenue for the third quarter of 2021, although its net income slipped slightly. The company saw its strongest growth in its laboratory products and services and analytical instruments segments.

For the period (end-October 2), Thermo Fisher's revenue grew 9% to $9.33 billion in the third quarter of 2021 compared to $8.521 billion for the same quarter of 2020. The company's net income was $1.902 billion for the third quarter of 2021 compared to $1.933 billion for the same period in 2020.

By market segment, the reported results are as follows.

Additionally, Thermo Fisher announced that it had several product launches -- including a new mass spectrometer and a new polymerase chain reaction system that enables advancements in oncology, cell and gene therapies -- as well as other research during this quarter.

Thermo Fisher opening new biologics site in Switzerland
Thermo Fisher Scientific recently assumed operational responsibility for a new biologics manufacturing site in Lengnau, Switzerland, the company announced.

Thermo Fisher seeks grant proposals that leverage NGS
Thermo Fisher Scientific is accepting new proposals that leverage next-generation sequencing (NGS) for its Oncomine Clinical Research Grant.

Thermo Fisher releases NanoDrop Eight spectrophotometer
Thermo Fisher Scientific is releasing the NanoDrop Eight UV-Vis microvolume spectrophotometer, which replaces the NanoDrop 8000 system, the company announced.

Thermo Fisher reports high revenues in Q2
Thermo Fisher Scientific reported a significant revenue increase during the second quarter of 2021.

Thermo Fisher announces Q1 revenue increase
Thermo Fisher Scientific said that its efforts to help scale vaccine production and support diagnostic testing globally during the COVID-19 pandemic were...